Skip to main content

Find Clinical Trials

Home
Conditions
Malignant Melanoma

Clinical trial condition

Malignant Melanoma

Explore clinical trials studying Malignant Melanoma. Study availability and eligibility vary by location and protocol.

168 public trials 20 recruiting studies

Refine in advanced search Browse all conditions

Malignant Melanoma trial results

Recruiting

Video-Tumorboard PLUS

NCT06980740

Conditions: Malignant Melanoma, Melanoma, Neoplasms, +11 more
Locations: Abteilung für Integrierte Onkologie - CIO Bonn, Universitätsklinikum Bonn Bonn, Germany

Nationales Centrum für Tumorerkrankungen Klinik u. Poliklinik für Dermatologie, Universitätsklinikum Dresden Dresden, Germany

Westdeutsches Tumorzentrum Münster, Universitätsklinikum Münster Münster, Germany

View Trial Details

Recruiting

RAPA-201 Therapy of Solid Tumors

NCT05144698

Conditions: Bronchial Neoplasms, Carcinoma, Carcinoma, Bronchogenic, +38 more
Locations: Hackensack University Medical Center Hackensack, New Jersey, United States

View Trial Details

Recruiting

Follow-up of a National Cohort of Melanoma Resectable Stage II, Stage III or IV Patients or Unresectable Primary

NCT02828202

Conditions: Malignant Melanoma, Melanoma, Neoplasms, +10 more
Locations: CHU d'Amiens Amiens, France

CH Annecy Genevois Annecy, France

CHU de Besançon Besançon, France

Assistance Publique - Hôpitaux de Paris (AP-HP), Hôpital Avicennes Bobigny, France

View all 27 locations

View Trial Details

Recruiting

A Randomized Trial to Assess the Role of Imaging During Follow Up After Radical Surgery of High Risk Melanoma

NCT03116412

Conditions: Malignant Melanoma, Melanoma, Neoplasms, +10 more
Locations: Södra Älvsborgs sjukhus Borås, Sweden

Mälarsjukhuset Eskilstuna Eskilstuna, Sweden

Falu lasarett Falun, Sweden

Gävle sjukhus Gävle, Sweden

View all 20 locations

View Trial Details

Recruiting

Carbon Ion Radiation Therapy in the Treatment of Mucous Melanomas of the Female Lower Genital Tract

NCT05478876

Conditions: Gynecologic Cancer, Malignant Melanoma, Melanoma, +11 more
Locations: CNAO Pavia, Italy

View Trial Details

Recruiting

GM103 Intratumoral Injection in Patients With Locally Advanced, Unresectable, Refractory and/or Metastatic Solid Tumors

NCT06265025

Conditions: Adenocarcinoma, Breast Cancer, Breast Diseases, +47 more
Locations: National Cancer Center Goyang-si, Gyeonggi-do, South Korea

Korea University Anam Hospital Seoul, South Korea

Hanyang University Seoul Hospital Seoul, South Korea

Severance Hospital, Yonsei University Health System Seoul, South Korea

View Trial Details

Recruiting

Study of CRX100 as Monotherapy and in Combination With Pembrolizumab in Patients With Advanced Solid Malignancies

NCT04282044

Conditions: Adenocarcinoma, Adnexal Diseases, Breast Diseases, +64 more
Locations: HonorHealth Research Institute Scottsdale, Arizona, United States

UC San Diego Moores Cancer Center La Jolla, California, United States

Stanford University Stanford, California, United States

View Trial Details

Recruiting

Melanoma Metastasized to the Brain and Steroids

NCT03563729

Conditions: Brain Diseases, Brain Neoplasms, Central Nervous System Diseases, +16 more
Locations: Herlev Universityhospital Herlev, Capital Region, Denmark

Aarhus Universityhospital Aarhus, Midt, Denmark

Odense Universityhospital Odense, Syd, Denmark

View Trial Details

Recruiting

The Gut Microbiome and Immune Checkpoint Inhibitor Therapy in Solid Tumors

NCT05037825

Conditions: Adenocarcinoma, Breast Diseases, Breast Neoplasms, +37 more
Locations: Baptist Health Clinical Research Elizabethtown, Kentucky, United States

View Trial Details

Recruiting

A Randomized Controlled Phase II Trial With Intradermal IMO-2125 in Pathological Tumor Stage (p) T3-4 cN0M0 Melanoma

NCT04126876

Conditions: Malignant Melanoma, Melanoma, Neoplasms, +10 more
Locations: VU Medical Centere Amsterdam, Netherlands

View Trial Details